Management of ischemic proctitis with severe rectal haemorrhage: a case report.

Acute ischemic proctitis is a rare pathological condition. We report here a patient presented with massive rectal haemorrhage from a bleeding vessel superimposed on an underlying pathology of ischemic proctitis. This case report illustrates the difficulties in making the clinical distinction between ischemic proctitis and other pathological entities. We also discussed the beneficial role of arteriogram with embolotherapy as an effective therapeutic measure in the management of lower gastrointestinal bleeding. The literature on the subject is reviewed.

An analysis of risk factors associated with failure of below knee amputations.

BACKGROUND: Below knee amputation (BKA) is often required in patients with critical limb ischemia. When such a procedure fails, an above knee revision (AKA) is required. This can cause further complications in this group of patients, who already have a high incidence of medical co-morbidities. METHODS: Case records of 47 patients (51 procedures performed) with BKA for peripheral vascular diseases during a 4-year period were reviewed. Clinical factors were analyzed using bi- and multi-variate analysis against the procedure outcome. Degree of social deprivation was evaluated with DEPCAT score in relation to amputation failure. Each arterial segment of the pre-operative arteriograms was scored based on a 3-point scoring system (0=normal, 1=stenosis, and 2=cclusion). With the assignment of an arbitrary weight for each segment, a total arterial score (TAS) was derived for each patient. RESULTS: Eighteen percent of BKA (n=9) failed. Absence of popliteal pulse (failure vs. success: 100% vs. 63%, P=0.04), calf rest pain (67% vs. 20%, P=0.01), combination of calf rest pain and feet tissue loss (CRPFTL; 67% vs. 3%, P=0.00), postoperative stump trauma (44% vs. 10%, P=0.03), and wound infection (WI; 89% vs. 26%, P=0.00) were factors associated with the failure of a BKA in bivariate analysis. Using multiple logistic regression, WI (OR=14) and CRPFTL (OR=47) were found to be independent predictors for the outcome of BKA. No statistical significance was found between the DEPCAT score and the failure rate. TAS was significantly higher in the failure group (median=17 vs. 9; P=0.00). CONCLUSIONS: This study suggests that CRPFTL and postoperative WI are predictor variables for the failure of a BKA. In addition, there is the potential role of arteriogram scoring in predicting the outcome of a BKA.

Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast.

The development of an invasive recurrence following treatment for ductal carcinoma in situ (DCIS) converts a non-fatal disease to one associated with mortality. To date, no pathological or molecular features have been found to predict for the type of recurrence. Previous studies have suggested that in DCIS angiogenesis may be an important factor in determining the transformation from in situ to invasive carcinoma. We looked at 355 cases of DCIS and found that 32 had subsequently developed recurrent disease. In these 32 cases and in matched controls, periductal vascular density was determined using morphometry and anti-endothelial antibodies, von Willebrand factor (vWF) and CD34. Vascular density was related to the risk of both invasive and in situ recurrence. Normal lobules at least 2 mm away were used as controls. Differences in the phenotype of individual blood vessels was detected by performing dual staining immunofluorescence on selected cases. The microvessel density (MVD), as detected with the CD34 antibody, was higher around foci of DCIS than around normal breast lobules (P=0.001). Furthermore, it was significantly higher in cases of DCIS that recurred (P<0.0001). The findings with the vWF antibody were less clear cut and suggested a trend in decreasing MVD with increasingly aggressive disease. Dual immunofluorescence staining shows that the increase in MVD seen around DCIS is due to an increase in CD34+/vWF-blood vessels. An increase in CD34+/vWF-of blood vessels may be able to predict cases of DCIS that are at a high risk of developing a recurrence.

Angiogenesis in pre-invasive cancers.

BACKGROUND: To date, research in the role of angiogenesis in cancer has focused mainly on invasive diseases. Measurement of the intra-tumoural microvessel density (MVD) has also been found to be an independent prognostic marker. More recently, natural angiogenic inhibitors and pharmacological drugs capable of suppressing specific stages of neovascularisation have been reported. METHODS: This review article concentrates on those angiogenesis-related findings in pre-invasive disease. RESULTS AND CONCLUSION: The study of angiogenesis in early and preneoplastic lesions is still at a preliminary stage. Current work provides indirect evidence, either from clinical or experimental studies only, most of which have used animal models. The use of the MVD as a marker of potential tumour invasion in pre-neoplastic disease is an attractive proposition. However, its prognostic values remain to be evaluated. Measurement of angiogenic factors, or their expression in certain pre-malignant conditions, may provide further information as to which disease may become invasive, and could possibly be used as a follow-up tool. The current treatment of pre-malignant conditions is usually surgical, although the early results of anti-angiogenesis therapy in animal models show encouraging results. Prevention is always better than cure, and the identification of pre-malignant lesions with intervention to prevent malignant transformation may soon become a realistic goal.